François Garnier

Ipsen (Paris)
Executive Vice-President, General Counsel

François Garnier was appointed Executive Vice-President, General Counsel of Ipsen in December 2014. François Garnier began his career in 1989 at Servier S.A. as International Contracts Manager and remained with the firm until September 1995. He then moved to Rhône Poulenc Rorer S.A. in 1995, to take up the position of Counsel for Corporate Transactions. In 1996 he moved to the United States as Associate Counsel, before being appointed Chief Counsel for France in 1999. François Garnier continued his career as Chief Counsel at Aventis Animal Nutrition until 2001, when he joined the Pharmacia Group as Chief Counsel for Europe. He joined Pfizer France in 2003, as Vice-President, General Counsel before moving on to become Chief Counsel for Pfizer’s operations in Europe from 2009 to 2014. François Garnier was International Chief Counsel (outside the US) of Pfizer Inc. since January 2014. Former student from the IEP of Paris and graduated from the University of Panthéon-Assas, François Garnier worked in the legal department of a number of pharmaceutical groups.

Auteurs associés

French Competition Authority (Paris)
University Paris I Panthéon-Sorbonne
French State Council (Paris)
Institut d’économie Industrielle (IDEI)
ESSEC Business School
FTI Consulting (Brussels)
Italian Senate
StartupDelta

Articles

274 Bulletin

Dimitri Giotakos, François Garnier, Laurent Petit, Peter De Luyck The European Commission prohibits a merger between two US companies active in the markets for aero-engines, avionics and other aircraft components and systems (GE/Honeywell)

274

"General Electric/Honeywell — An insight into the Commission’s investigation and decision"* whereas the order backlog is an indication of their immediate future incumbency. Owing to the benefits of engine commonality, incumbency of engine suppliers is better assessed in terms of the installed (...)

13402 Revue

Envoyer un message